Main Logo
ESMO TAT 2024
ESMO TAT 2024
Mary GreccoESMO TAT 2024 | April 30, 2024
Cancer organoid-based drug sensitivity tests have recently been investigated to predict responses to anticancer drugs.
Read More
Mary GreccoESMO TAT 2024 | April 30, 2024
A study that assessed the impact of miR-29a and miR-143 on gene expression in lung cancer.
Mary GreccoESMO TAT 2024 | April 25, 2024
A study examined whether AI and clinical knowledge can identify more patients with lung and ovarian cancers.
Mary GreccoESMO TAT 2024 | April 25, 2024
A study detailed the landscape of lung adenocarcinoma progression.
Mary GreccoESMO TAT 2024 | April 25, 2024
MK-1084 as monotherapy and in combination with pembrolizumab is effective in patients with NSCLC.
Latest News
August 29, 2025

Physician's Weekly

Family Practice

FDA Approves Gardenia-Based Blue Dye for Use in Foods and Drinks

Learn More